{"id":21408,"date":"2023-09-06T12:38:03","date_gmt":"2023-09-06T10:38:03","guid":{"rendered":"\/?p=21408"},"modified":"2024-04-11T12:28:01","modified_gmt":"2024-04-11T10:28:01","slug":"theranostics-platform-for-precise-and-predictive-treatment-of-visual-disorders","status":"publish","type":"post","link":"https:\/\/www.ino.cnr.it\/?p=21408","title":{"rendered":"Theranostics platform for precise and predictive treatment of visual disorders"},"content":{"rendered":"

Regensight<\/a> is an Italian start-up company based in Rome. It has developed a breakthrough platform based upon theranostic technology for correcting major visual disorders at all ages and is clinically validating it. Theranostics is a breakthrough medical solution based on therapy guided by imaging diagnostics for providing tailored therapies. The Regensight platform improves vision by inducing the controlled photo-polymerization process of corneal tissue proteins through UV-A light mediated delivery and photo-activation of a bio-chromophore in the cornea.<\/p>\n

Regensight for treatment of visual disorders<\/a>
\n <\/p>\n

Patents:
\n\u25a0 “Process for dosing a chromophoric agent in a corneal tissue and apparatus for controlling the dose<\/a>“.IT102016000007349, EP3407920, US20210196511 e CN108697814B<\/p>\n

\u25a0 “Device, system and method for treating a corneal tissu<\/a>e\u201d. IT102019000010341, EP3989895, US20220233842 e CN114025835<\/p>\n

\u25a0 “Liquid formulation, in particular to treat a corneal tissue<\/a>“. IT102019000011985, US20230131004 e CN114126650<\/p>\n

TRL 9 for the treatment of Keratoconus.
\nTRL 4 for the treatment of Myopia e Presbyopia.<\/p>\n

\"\"<\/a>

Download leaflet<\/p><\/div>\n

 <\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Regensight is an Italian start-up company based in Rome. It has developed a breakthrough platform based upon theranostic technology for correcting major visual disorders at all [\u2026]<\/span><\/p>\n","protected":false},"author":70568,"featured_media":21411,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[244],"tags":[245,291,292,247,246],"class_list":["post-21408","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technological-leaflet","tag-biophotonics","tag-medical-device","tag-ophthalmology","tag-theranostics","tag-visual-disorders"],"_links":{"self":[{"href":"https:\/\/www.ino.cnr.it\/index.php?rest_route=\/wp\/v2\/posts\/21408","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ino.cnr.it\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ino.cnr.it\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ino.cnr.it\/index.php?rest_route=\/wp\/v2\/users\/70568"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ino.cnr.it\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21408"}],"version-history":[{"count":23,"href":"https:\/\/www.ino.cnr.it\/index.php?rest_route=\/wp\/v2\/posts\/21408\/revisions"}],"predecessor-version":[{"id":23163,"href":"https:\/\/www.ino.cnr.it\/index.php?rest_route=\/wp\/v2\/posts\/21408\/revisions\/23163"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ino.cnr.it\/index.php?rest_route=\/wp\/v2\/media\/21411"}],"wp:attachment":[{"href":"https:\/\/www.ino.cnr.it\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21408"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ino.cnr.it\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21408"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ino.cnr.it\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21408"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}